Log In
BCIQ
Print this Print this
 

NI-1201

  Manage Alerts
Collapse Summary General Information
Company Novimmune S.A.
DescriptionHuman mAb that neutralizes interleukin-6 (IL-6) receptor complex (IL-6RC) activity
Molecular Target Interleukin-6 (IL-6) receptor (CD126)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today